Gene · 1548
Papers4,152
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,152
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness. | Front Pharmacol | 2025 | 40741006 | PubTator, text mining | PubMed |
| Characterizing oxidative metabolites of 6-methylnicotine (6MN; aka Metatine): divergent metabolism from nicotine and identification of urinary biomarkers of exposure. | Toxicol Sci | 2025 | 40690396 | PubTator, text mining | PubMed |
| Impact of CYP2A6 genetic polymorphism on letrozole efficacy in Iraqi women with polycystic ovary syndrome. | J Taibah Univ Med Sci | 2025 | 40687181 | PubTator, text mining | PubMed |
| Time-dependent inactivation of human cytochrome P450 2A6 variants and 2A13 by imperatorin: natural coumarins and imperatorin oxidation. | Biochem Pharmacol | 2025 | 40659132 | PubTator, text mining | PubMed |
| Extending Investigations of miR-126-5p on the Regulation of CYP2A6, the Major Nicotine-Inactivating Enzyme. | Pharmacol Res Perspect | 2025 | 40631526 | PubTator, text mining | PubMed |
| A Review on New Frontiers in Drug-Drug Interaction Predictions and Safety Evaluations with In Vitro Cellular Models. | Pharmaceutics | 2025 | 40574059 | PubTator, text mining | PubMed |
| Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 Inhibitors. | Curr Pharm Des | 2025 | 40454501 | PubTator, text mining | PubMed |
| Development of a TK6-derived cell line expressing four human cytochrome P450s for genotoxicity testing. | Toxicol In Vitro | 2025 | 40436327 | PubTator, text mining | PubMed |
| Unveiling the heritability of selected unexplored pharmacogenetic markers in the Saudi population. | Front Pharmacol | 2025 | 40376268 | PubTator, text mining | PubMed |
| Buffer compositions strongly impact the in vitro assessment of CYP fraction metabolized using human liver microsomes or expressed isoenzymes. | Drug Metab Pharmacokinet | 2025 | 40347678 | PubTator, text mining | PubMed |
| Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci. | Hum Mol Genet | 2025 | 40341939 | PubTator, text mining | PubMed |
| Cinnamaldehyde attenuates CCL4-induced liver fibrosis by inhibiting the CYP2A6/Notch3 pathway. | Arab J Gastroenterol | 2025 | 40328565 | PubTator, text mining | PubMed |
| Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the in vivo prediction of individual hepatic clearance. | J Gastrointest Oncol | 2025 | 40115928 | PubTator, text mining | PubMed |
| Pharmacogenomic variants in the Pumi population from Yunnan, China. | Gene | 2025 | 40113188 | PubTator, text mining | PubMed |
| Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions. | Precis Clin Med | 2025 | 40110576 | PubTator, text mining | PubMed |
| Theoretical Study on the Metabolic Mechanism of Heptachlor in Human Cytochrome P450 Enzymes. | Int J Mol Sci | 2025 | 40076644 | PubTator, text mining | PubMed |
| CYP2A6 suppresses hepatocellular carcinoma via inhibiting SRC/Wnt/β-Catenin pathway. | Acta Pharmacol Sin | 2025 | 40069491 | PubTator, text mining | PubMed |
| Smoking behavior-related genetic variants and lung cancer risk in Japanese: an assessment by mediation analysis. | Carcinogenesis | 2025 | 40059777 | PubTator, text mining | PubMed |
| Evaluation of reversible cytochrome P450 inhibition by Withania somnifera leaf and root extracts. | Drug Metab Dispos | 2025 | 40023576 | PubTator, text mining | PubMed |
| Role of Cytochromes P450 in Intestinal Barrier Function: Possible Involvement in the Pathogenesis of Leaky Gut Syndrome. | Dig Dis Sci | 2025 | 39971825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1548/papers?page=4